chevron_leftBack
As of 14 June 2026, Beijing Beilu Pharmaceutical Co., Ltd. has a market cap of $799.95M USD, ranking #12051 globally and #3550 in China.
It ranks #1095 in the Healthcare sector, and #410 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$799.95MUSD
5.42B CNY
Enterprise Value
$800.91MUSD
5.42B CNY
Revenue (TTM)
$177.87MUSD
1.21B CNY
EBITDA (TTM)
$29.32MUSD
198.44M CNY
Net Income (TTM)
$13.69MUSD
92.73M CNY
EBITDA Margin
16%
Profit Margin
7.7%
PE Ratio
53.5
PS Ratio
4.5
PB Ratio
2.2
EV/EBITDA
27.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Xu Wang
open_in_new
Employees
1,173
Founded
1992
Website
beilu.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.7% | -1.9% | -2% | 6.1% | 12% | 55% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300016
北京北陆药业股份有限公司 Class A
ISIN: CNE000001QK9
Shares Out.:
Shares Outstanding:
581.69M1
Shares Float:
545.998M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
9.47 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules. It also offers gadolinium-based agents, including gadopentetate dimeglumine and gadobutrol, as well as iodine-based agents comprising iohexol, ioversol, iodixanol, iopromide, and iopamidol, as well as oral anti-diabetic drugs. The company was founded in 1992 and is based in Beijing, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
7K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
6K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
3K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
95K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
68K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
45K%
|
97.4
|
|
SIX: RO
|
$321.52B
40K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
36K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
34K%
218.9B CHF
|
20.5
|
chevron_leftBack